SELECT-2 Clinical Trial Assessing the Efficacy and Saftey of Controlled-Release Interferon Alpha-2B (CR2b)+Ribavirin (RBV) Versus Pegylated Interferon Alpha-2B (Peg2b)+RBV in Treatment-NaïVE Genotype-1 (G1) Hepatitis C
Autor: | Younossi, Zobair M., Lawitz, Eric J., Krastev, Zahary, Rigney, Amy, Tchernev, Konstantin, Takov, Dimitar, Ghalib, Reem H., Long, Walker A. |
---|---|
Zdroj: | In Gastroenterology 2011 140(5) Supplement 1:S |
Databáze: | ScienceDirect |
Externí odkaz: |